glp-1 type 1 diabetes news Medications for GLP-1-based therapies for diabetes, obesity

The utility of Exenate extends beyond single-drug therapyit is approved for concurrent use with other antidiabetic agents like sulfonylureas, metformin or thiazolidinediones

There were concerns about side effects, but Lilly said it did not observe any cardiac or liver issues

A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse)

This is a real consideration for people on the standard titration schedule who will eventually reach 10mg or 15mg doses

The product is being developed by Adalvo and will be marketed by Sandoz in Brazil

Esta pigmentacin es causada por el aumento de melanina en respuesta a la irritacin continua del tabaco